[1]王恺皞,综述,蒋雄京,等.顽固性高血压的器械治疗[J].心血管病学进展,2016,(2):112-117.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.004]
　WANG Kaihao,JIANG Xiongjing.Device-based Therapies for Resistant Hypertension[J].Advances in Cardiovascular Diseases,2016,(2):112-117.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.004]
点击复制

顽固性高血压的器械治疗()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年2期
页码:
112-117
栏目:
综述
出版日期:
2016-04-20

文章信息/Info

Title:
Device-based Therapies for Resistant Hypertension
作者:
王恺皞; 综述; 蒋雄京; 审校
中国医学科学院 阜外心血管病医院,北京 100037
Author(s):
WANG Kaihao;  JIANG Xiongjing
Department of Cardiology, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100037,China
关键词:
顽固性高血压;  器械治疗;  降压
Keywords:
Resistant hypertension;  Device-based therapies;  Anti-hypertension
分类号:
R544.1
DOI:
10.16806/j.cnki.issn.1004-3934.2016.02.004
文献标志码:
A
摘要:
尽管抗高血压药物快速进展,仍然有部分高血压患者的血压经规范的降压治疗无法达标,成为临床上棘手的难治性高血压。近年来,基于器械的降压治疗方法开始被重视,现对各种类型正在研发的可能有潜在临床应用价值的用于治疗难治性高血压的器械做一综述。
Abstract:
Despite the development of anti-hypertension drugs, the blood pressure of many hypertensive patients remains hard to control.In recent years, device-based therapies are getting increasing attention.Here is to make a review of the new types of devices that are currently being researched and have the clinical potential of treating resistant hypertension.

参考文献/References:

[1] 蒋雄京.中国高血压联盟关于经皮经导管射频消融去肾交感神经术治疗难治性高血压的立场与建议[J].中国医学前沿杂志,2013,5(9):51-56.
[2] White WB, Galis ZS, Henegar J.Renal denervation therapy for hypertension:pathways for moving development forward[J].J Am Soc Hypertens,2015,9(5):341-350.
[3] Bunte MC, de Oliveira EI, Shishehbor MH.Endovascular treatment of resistant and uncontrolled hypertension therapies on the horizon[J].JACC Cardiovasc Interv,2013,6(1):1-9.
[4] Symplicity HTN-1 Investigators.Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months[J].Hypertension,2011,57(5): 911-917.
[5] Esler MD, Krum H, Schlaich M, et al.Renal sympathetic denervation for treatment of drug-resistant hypertension:one-year results from the symplicity HTN-2 randomized, controlled trial[J].Circulation,2012,126(25):2976-2982.
[6] Bhatt DL, Kandzari DE, O'Neill WW, et al.A controlled trial of renal denervation for resistant hypertension[J].N Engl J Med,2014,370(15):1393-1401.
[7] Worthley SG, Tsioufis CP, Worthley MI, et al.Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension:the EnligHTN I trial[J].Eur Heart J,2013,34(28):2132-2140.
[8] Ormiston JA, Watson T, van Pelt N, et al.Renal denervation for resistant hypertension using an irrigated radiofrequency balloon:12-month results from the Renal Hypertension Ablation System(RHAS)trial[J].EuroIntervention,2013,9(1):70-74.
[9] Dong H, Jiang X, Liang T, et al.Transradial renal denervation for the treatment of resistant hypertension[J].J Invasive Cardiol,2014,26(7):322-327.
[10] 蒋雄京, 董徽.SYMPLICITY+HTN-3结果阴性不能否定经导管肾神经消融理念[J].中国循环杂志,2014, 29(6):404-405.
[11] Mabin T, Sapoval M, Cabane V, et al.First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension[J].EuroIntervention,2012,8(1):57-61.
[12] Wang Q, Guo R, Rong S, et al.Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model[J].J Am Coll Cardiol,2013,61(21): 2185-2192.
[13] Rong S, Zhu H, Liu D, et al.Noninvasive renal denervation for resistant hypertension using high-intensity focused ultrasound[J].Hypertension,2015,66:22-25.
[14] Streitparth F, Walter A, Stolzenburg N, et al.MR-guided periarterial ethanol injection for renal sympathetic denervation: a feasibility study in pigs[J].Cardiovasc Intervent Radiol,2013,36(3):791-796.
[15] Firouznia K, Hosseininasab SJ, Amanpour S, et al.Renal sympathetic denervation by CT-scan-guided periarterial ethanol injection in sheep[J].Cardiovasc Intervent Radiol,2015,38(4):977-984.
[16] Stefanadis C.Renal denervation in resistant hypertension:radiofrequency ablation and chemical denervation[J].Hellenic J Cardiol,2011,52(6):481-482.
[17] Fischell TA, Fischell DR, Ghazarossian VE, et al.Next generation renal denervation:chemical “perivascular” renal denervation with alcohol using a novel drug infusion catheter[J].Cardiovasc Revasc Med,2015,16(4):221-227.
[18] Ji M, Shen L, Wu YZ, et al.Short-term safety and efficiency of cryoablation for renal sympathetic denervation in a swine model[J].Chin Med J(Engl),2015,128(6):790-794.
[19] Prochnau D, Heymel S, Otto S, et al.Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation[J].EuroIntervention,2014,10(5):640-645.
[20] Saha SP, Ziada KM, Whayne TF.Surgical, interventional, and device innovations in the management of hypertension[J].Int J Angiol,2015,24(1):1-10.
[21] Bisognano JD, Bakris G, Nadim MK, et al.Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension:results from the double-blind, randomized, placebo-controlled rheos pivotal trial[J].J Am Coll Cardiol,2011,58:765-773.
[22] Bloch MJ, Basile JN.The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension:back to the drawing board[J].J Clin Hypertens(Greenwich),2012,14:184-186.
[23] Hoppe UC, Brandt MC, Wachter R, et al.Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile:results from the Barostim neo trial[J].J Am Soc Hypertens,2012,6:270-276.
[24] ROX CONTROL HTN Investigators.Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension(the ROX CONTROL HTN study):a randomised controlled trial[J].Lancet,2015,385:1634-1641.
[25] Burchell AE, Lobo MD, Sulke N, et al.Arteriovenous anastomosis:is this the way to control hypertension[J].Hypertension,2014, 64: 6-12.
[26] Kapil V, Sobotka PA, Saxena M, et al.Central iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulation[J].Curr Hypertens Rep,2015,17:585-586.
[27] Green AL, Wang S, Bittar RG, et al.Deep brain stimulation:a new treatment for hypertension?[J].J Clin Neurosci,2007,14:592-595.
[28] Patel NK, Javed S, Khan S, et a1.Deep brain stimulation relieves refractory hypertension[J].Neurology,2011,76:405-407.
[29] Carter HH, Dawson EA, Cable NT, et al.Deep brain stimulation of the periaqueductal grey induces vasodilation in humans[J].Hypertension,2011,57:24-25.
[30] O'Callaghan EL, McBryde FD, Burchell AE, et al.Deep brain stimulation for the treatment of resistant hypertension[J].Curr Hypertens Rep,2014,16:493.
[31] Mahtani KR, Nunan D, Heneghan CJ.Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis[J].J Hypertens,2012,30:852-860.

相似文献/References:

[1]鄢学,李承治,张帆,等.肾动脉消融治疗顽固性高血压的相关影响因素[J].心血管病学进展,2016,(3):311.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.026]
　YAN Xue,LI Chengzhi,ZHANG Fan,et al.The Related Factors of Renal Denervation for Resistant Hypertension[J].Advances in Cardiovascular Diseases,2016,(2):311.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.026]
[2]肖蓉雪 刘宗军.肾动脉去交感神经术治疗顽固性高血压的研究进展[J].心血管病学进展,2019,(8):1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
　XIAO Rongxue,LIU Zongjun.Treatment of Resistant Hypertension by Renal Denervation[J].Advances in Cardiovascular Diseases,2019,(2):1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]

备注/Memo

备注/Memo:
作者简介:王恺皞(1991—),在读硕士,主要从事高血压研究。Email: 1445347106@qq.com 通信作者:蒋雄京(1966—),主任医师,硕士,主要从事外周血管病和高血压的基础及临床研究。Email: jxj103@hotmail.com
更新日期/Last Update: 2016-03-25